LEADS BIOLABS-B (09887) sees Xiaoqiang Kang sell 16,500 shares on the SEHK open market at an average of HKD 43.6720 per share on October 20, 2026, involving about HKD 720,588, an on-exchange active trade matched on the SEHK open market and therefore a direct secondary-market dealing; according to the supplementary information, the sale was executed by a controlled entity serving as the company’s share incentive platform upon employees’ instructions, and the declarant stated he did not reduce his personal direct holding.
Prior to the disposal, Xiaoqiang Kang’s long position in LEADS BIOLABS-B was 29.52 million shares, representing 14.93%; following the disposal, the holding changed to 29.50 million shares, with the long position ratio falling to 14.92%.
This involves related parties: Lai Shoupeng.
Comments